OpenAI Fuels Sam Altman’s Merge Labs in Brain-Tech Push

OpenAI has taken a bold step into brain-computer interface technology by backing Merge Labs, a startup founded by its CEO Sam Altman. Announced on January 15, 2026, Merge Labs positions itself as a research lab dedicated to bridging biological and artificial intelligence to expand human potential.  

The investment highlights Altman’s growing influence in frontier technologies and sets up a direct rivalry with Elon Musk’s Neuralink, which is also developing BCIs to restore lost abilities and enhance human cognition.  

Key Highlights

• Funding & Valuation: Merge Labs raised $250 million in seed funding, reaching an $850 million valuation.  
• OpenAI’s Role: OpenAI contributed the largest investment in the round.  
• Mission: Develop non-invasive neural technologies to improve brain health, restore abilities, and enable deeper human-AI collaboration.  
• Other Backers: Investors include Bain Capital and Valve co-founder Gabe Newell.  
• Competitive Edge: The move intensifies Altman’s rivalry with Musk’s Neuralink, spotlighting the race to dominate the BCI sector.  
• Vision: Merge Labs envisions BCIs as a natural interface for creativity, communication, and learning in the AI era.  

Sources: Business Today, Mint, TechCrunch